234 related articles for article (PubMed ID: 9553136)
21. Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation.
Friedmann MC; Migone TS; Russell SM; Leonard WJ
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2077-82. PubMed ID: 8700888
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-2 (IL-2)-mediated induction of the IL-2 receptor alpha chain gene. Critical role of two functionally redundant tyrosine residues in the IL-2 receptor beta chain cytoplasmic domain and suggestion that these residues mediate more than Stat5 activation.
Ascherman DP; Migone TS; Friedmann MC; Leonard WJ
J Biol Chem; 1997 Mar; 272(13):8704-9. PubMed ID: 9079703
[TBL] [Abstract][Full Text] [Related]
23. Regulation of IL-2 signaling.
Higuchi M; Asao H; Tanaka N; Oda K; Takeshita T; Sugamura K
Leukemia; 1997 Apr; 11 Suppl 3():416-7. PubMed ID: 9209410
[TBL] [Abstract][Full Text] [Related]
24. Efficient internalization of IL-2 depends on the distal portion of the cytoplasmic tail of the IL-2R common gamma-chain and a lymphoid cell environment.
Yu A; Olosz F; Choi CY; Malek TR
J Immunol; 2000 Sep; 165(5):2556-62. PubMed ID: 10946282
[TBL] [Abstract][Full Text] [Related]
25. The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction.
Saharinen P; Silvennoinen O
J Biol Chem; 2002 Dec; 277(49):47954-63. PubMed ID: 12351625
[TBL] [Abstract][Full Text] [Related]
26. Receptor expression is essential for proliferation induced by dimerized Jak kinases.
Fujii H
Biochem Biophys Res Commun; 2008 Jun; 370(4):557-60. PubMed ID: 18381062
[TBL] [Abstract][Full Text] [Related]
27. Involvement of proteasomes in regulating Jak-STAT pathways upon interleukin-2 stimulation.
Yu CL; Burakoff SJ
J Biol Chem; 1997 May; 272(22):14017-20. PubMed ID: 9162019
[TBL] [Abstract][Full Text] [Related]
28. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID.
Russell SM; Johnston JA; Noguchi M; Kawamura M; Bacon CM; Friedmann M; Berg M; McVicar DW; Witthuhn BA; Silvennoinen O
Science; 1994 Nov; 266(5187):1042-5. PubMed ID: 7973658
[TBL] [Abstract][Full Text] [Related]
29. Protein phosphatase 2A regulates interleukin-2 receptor complex formation and JAK3/STAT5 activation.
Ross JA; Cheng H; Nagy ZS; Frost JA; Kirken RA
J Biol Chem; 2010 Feb; 285(6):3582-3591. PubMed ID: 19923221
[TBL] [Abstract][Full Text] [Related]
30. Differential substrate recognition capabilities of Janus family protein tyrosine kinases within the interleukin 2 receptor (IL2R) system: Jak3 as a potential molecular target for treatment of leukemias with a hyperactive Jak-Stat signaling machinery.
Witthuhn BA; Williams MD; Kerawalla H; Uckun FM
Leuk Lymphoma; 1999 Jan; 32(3-4):289-97. PubMed ID: 10037026
[TBL] [Abstract][Full Text] [Related]
31. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling.
Sporri B; Kovanen PE; Sasaki A; Yoshimura A; Leonard WJ
Blood; 2001 Jan; 97(1):221-6. PubMed ID: 11133764
[TBL] [Abstract][Full Text] [Related]
32. Constitutive association of JAK1 and STAT5 in pro-B cells is dissolved by interleukin-4-induced tyrosine phosphorylation of both proteins.
Erhardt I; Lischke A; Sebald W; Friedrich K
FEBS Lett; 1998 Nov; 439(1-2):71-4. PubMed ID: 9849880
[TBL] [Abstract][Full Text] [Related]
33. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
[TBL] [Abstract][Full Text] [Related]
34. Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).
Nielsen M; Svejgaard A; Röpke C; Nordahl M; Odum N
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10995-9. PubMed ID: 7479924
[TBL] [Abstract][Full Text] [Related]
35. Homodimerization of IL-2 receptor beta chain is necessary and sufficient to activate Jak2 and downstream signaling pathways.
Ferrag F; Pezet A; Chiarenza A; Buteau H; Nelson BH; Goffin V; Kelly PA
FEBS Lett; 1998 Jan; 421(1):32-6. PubMed ID: 9462834
[TBL] [Abstract][Full Text] [Related]
36. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.
Han HS; Jun HS; Utsugi T; Yoon JW
J Autoimmun; 1997 Jun; 10(3):299-307. PubMed ID: 9218758
[TBL] [Abstract][Full Text] [Related]
37. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.
Johnston JA; Bacon CM; Finbloom DS; Rees RC; Kaplan D; Shibuya K; Ortaldo JR; Gupta S; Chen YQ; Giri JD
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8705-9. PubMed ID: 7568001
[TBL] [Abstract][Full Text] [Related]
38. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes.
Beadling C; Guschin D; Witthuhn BA; Ziemiecki A; Ihle JN; Kerr IM; Cantrell DA
EMBO J; 1994 Dec; 13(23):5605-15. PubMed ID: 7988557
[TBL] [Abstract][Full Text] [Related]
39. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
[TBL] [Abstract][Full Text] [Related]
40. IL-2 receptor signaling through the Shb adapter protein in T and NK cells.
Lindholm CK
Biochem Biophys Res Commun; 2002 Aug; 296(4):929-36. PubMed ID: 12200137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
